Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer.
Ayumi ShikamaTakeo MinaguchiWataru TakaoYoshihiko HosokawaKeiko NishidaNobutaka TasakaAzusa AkiyamaManabu SakuraiHiroyuki OchiToyomi SatohPublished in: International journal of clinical oncology (2019)
Patients with endometrioid histology and PS 0 should be offered SCS for recurrent EC. Prospective trials are warranted to verify this proposal.